Tumor necrosis factor α and interleukin-1β stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells
- 1 January 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Pain
- Vol. 113 (1) , 113-122
- https://doi.org/10.1016/j.pain.2004.09.031
Abstract
Tumor necrosis factor alpha (TNFalpha) and interleukin 1beta (IL-1beta) are pro-inflammatory cytokines capable of altering the sensitivity of sensory neurons. Because sensitization elicited by IL-1beta and TNFalpha is blocked by inhibition of the inducible enzyme, cyclooxygenase-II (COX-2), we examined whether these cytokines could increase COX-2 expression in dorsal root ganglion (DRG) cultures. Treatment of cell cultures with either IL-1beta or TNFalpha increases immunoreactive COX-2, as measured by immunoblotting, in a time- and concentration-dependent manner. A 24-h pretreatment with 10 ng/ml IL-1beta or 50 ng/ml TNFalpha augmented COX-2 expression 50- and 8-fold over basal levels, respectively. Immunohistochemistry established the presence of COX-2-like immunoreactivity in both neuronal and non-neuronal cells in culture. The addition of IL-1 receptor antagonist blocked the induction of COX-2 expression by IL-1beta, but did not alter TNFalpha-stimulated increases in COX-2, indicating that the mechanism of TNFalpha is not limited to increasing the expression of IL-1beta. The basal and TNFalpha-induced expression of COX-2 was not dependent on the presence of NGF in the growth media. IL-1beta and TNFalpha treatment for 24 h enhanced prostaglandin E2 (PGE2) production 2-4-fold, which was blocked by pretreatment with the COX-2 inhibitor, NS-398. Exposing cultures to PGE2, IL-1beta, or TNFalpha for 24 h did not alter PGE2 receptor (EP) mRNA levels. These results indicate that TNFalpha and IL-1beta induce the functional expression of COX-2 but not EP receptors in DRG cells in culture and suggest that cytokine-induced sensitization of sensory neurons is secondary to prostaglandin production and not alterations in EP receptors.Keywords
This publication has 52 references indexed in Scilit:
- Changes in the Effect of Spinal Prostaglandin E2during Inflammation: Prostaglandin E (EP1-EP4) Receptors in Spinal Nociceptive Processing of Input from the Normal or Inflamed Knee JointJournal of Neuroscience, 2004
- Mechanism of interleukin‐1β‐induced calcitonin gene‐related peptide production from dorsal root ganglion neurons of neonatal ratsJournal of Neuroscience Research, 2003
- Allopregnanolone Activates GABAAReceptor/Cl−Channels in a Multiphasic Manner in Embryonic Rat Hippocampal NeuronsJournal of Neurophysiology, 2002
- Interleukin‐1β Induces Substance P Release from Primary Afferent Neurons Through the Cyclooxygenase‐2 SystemJournal of Neurochemistry, 1999
- Intrathecal NSAIDS attenuate inflammation-induced neuropeptide release from rat spinal cord slicesPain, 1998
- Prostanoids synthesized by cyclo‐oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitabilityBritish Journal of Pharmacology, 1997
- The Effect of Interleukin-1β and Interleukin-4 on the Expression of Prostaglandin Receptors EP1 and EP3 in Amnion WISH CellsAmerican Journal of Reproductive Immunology, 1997
- FAN, a Novel WD-Repeat Protein, Couples the p55 TNF-Receptor to Neutral SphingomyelinaseCell, 1996
- Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levelsInflammation Research, 1988
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.The Journal of Experimental Medicine, 1986